SCCE — Sachem Capital Corp.

NYSE · Real Estate · Equity Real Estate Investment Trusts (REITs) · CIK 1682220 ·
Last close
$24.32
Market Cap
52W High
$24.78
52W Low
$23.89
ADV30
3,898
Next earnings
Drugs Made In America Acquisition II Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. It intends to source and evaluate companies focused on the pharmaceutical sector. Drugs Made In America Acquisition II Corp. was incorporated in 2024 and is based in New York, New York.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Dec 2024 14,785,000 18,947,000 -4,822,000 -5,051,000 491,976,000 18,066,000 310,325,000

Annual Trend (SEC EDGAR, last 1y)

Revenues vs Net Income (last 1y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2024 -39,571,000 491,976,000 310,325,000

TTM Snapshot

Revenues TTM
$14,785,000
NetIncome TTM
$-5,051,000
OpCashFlow TTM
$0
Assets (Latest)
$491,976,000
Forward EPS

Peers — same industry

TickerNameMarket CapLastDaily %
WELL WELLTOWER INC. $168.93B $234.44
PLD Prologis, Inc. $134.93B $144.61
EQIX EQUINIX INC $100.57B $1019.28
BN BROOKFIELD Corp /ON/ $94.99B $42.53
AMT AMERICAN TOWER CORP /MA/ $80.78B $173.36

Recent Insider Activity

No insider activity indexed for this ticker.